218 related articles for article (PubMed ID: 37098965)
1. Splicing Factor SRSF1 Promotes Pancreatitis and KRASG12D-Mediated Pancreatic Cancer.
Wan L; Lin KT; Rahman MA; Ishigami Y; Wang Z; Jensen MA; Wilkinson JE; Park Y; Tuveson DA; Krainer AR
Cancer Discov; 2023 Jul; 13(7):1678-1695. PubMed ID: 37098965
[TBL] [Abstract][Full Text] [Related]
2. Splicing factor SRSF1 promotes gliomagenesis via oncogenic splice-switching of MYO1B.
Zhou X; Wang R; Li X; Yu L; Hua D; Sun C; Shi C; Luo W; Rao C; Jiang Z; Feng Y; Wang Q; Yu S
J Clin Invest; 2019 Feb; 129(2):676-693. PubMed ID: 30481162
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA DGCR5 involves in tumorigenesis of esophageal squamous cell carcinoma via SRSF1-mediated alternative splicing of Mcl-1.
Duan Y; Jia Y; Wang J; Liu T; Cheng Z; Sang M; Lv W; Qin J; Liu L
Cell Death Dis; 2021 Jun; 12(6):587. PubMed ID: 34099633
[TBL] [Abstract][Full Text] [Related]
4. YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK-STAT3 Signaling.
Gruber R; Panayiotou R; Nye E; Spencer-Dene B; Stamp G; Behrens A
Gastroenterology; 2016 Sep; 151(3):526-39. PubMed ID: 27215660
[TBL] [Abstract][Full Text] [Related]
5. IER3 supports KRASG12D-dependent pancreatic cancer development by sustaining ERK1/2 phosphorylation.
Garcia MN; Grasso D; Lopez-Millan MB; Hamidi T; Loncle C; Tomasini R; Lomberk G; Porteu F; Urrutia R; Iovanna JL
J Clin Invest; 2014 Nov; 124(11):4709-22. PubMed ID: 25250570
[TBL] [Abstract][Full Text] [Related]
6. SRSF1 Prevents DNA Damage and Promotes Tumorigenesis through Regulation of DBF4B Pre-mRNA Splicing.
Chen L; Luo C; Shen L; Liu Y; Wang Q; Zhang C; Guo R; Zhang Y; Xie Z; Wei N; Wu W; Han J; Feng Y
Cell Rep; 2017 Dec; 21(12):3406-3413. PubMed ID: 29262322
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of alternative splicing contributes to multiple myeloma pathogenesis.
Song S; Zhang W; Li Q; Wang Z; Su Q; Zhang X; Li B; Zhuang W
Br J Cancer; 2023 Apr; 128(6):1086-1094. PubMed ID: 36593359
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice.
Collins MA; Bednar F; Zhang Y; Brisset JC; Galbán S; Galbán CJ; Rakshit S; Flannagan KS; Adsay NV; Pasca di Magliano M
J Clin Invest; 2012 Feb; 122(2):639-53. PubMed ID: 22232209
[TBL] [Abstract][Full Text] [Related]
9. Mutant KRAS Mediates circARFGEF2 Biogenesis to Promote Lymphatic Metastasis of Pancreatic Ductal Adenocarcinoma.
Kong Y; Luo Y; Zheng S; Yang J; Zhang D; Zhao Y; Zheng H; An M; Lin Y; Ai L; Diao X; Lin Q; Chen C; Chen R
Cancer Res; 2023 Sep; 83(18):3077-3094. PubMed ID: 37363990
[TBL] [Abstract][Full Text] [Related]
10. miR-802 Suppresses Acinar-to-Ductal Reprogramming During Early Pancreatitis and Pancreatic Carcinogenesis.
Ge W; Goga A; He Y; Silva PN; Hirt CK; Herrmanns K; Guccini I; Godbersen S; Schwank G; Stoffel M
Gastroenterology; 2022 Jan; 162(1):269-284. PubMed ID: 34547282
[TBL] [Abstract][Full Text] [Related]
11. Ductal obstruction promotes formation of preneoplastic lesions from the pancreatic ductal compartment.
Cheng T; Zhang Z; Jian Z; Raulefs S; Schlitter AM; Steiger K; Maeritz N; Zhao Y; Shen S; Zou X; Ceyhan GO; Friess H; Kleeff J; Michalski CW; Kong B
Int J Cancer; 2019 May; 144(10):2529-2538. PubMed ID: 30412288
[TBL] [Abstract][Full Text] [Related]
12. SRSF1 inhibits autophagy through regulating Bcl-x splicing and interacting with PIK3C3 in lung cancer.
Lv Y; Zhang W; Zhao J; Sun B; Qi Y; Ji H; Chen C; Zhang J; Sheng J; Wang T; Dominguez D; Liu H; Liu Q; Meng S; Li X; Wang Y
Signal Transduct Target Ther; 2021 Mar; 6(1):108. PubMed ID: 33664238
[TBL] [Abstract][Full Text] [Related]
13. Targeting PRMT1-mediated SRSF1 methylation to suppress oncogenic exon inclusion events and breast tumorigenesis.
Li WJ; Huang Y; Lin YA; Zhang BD; Li MY; Zou YQ; Hu GS; He YH; Yang JJ; Xie BL; Huang HH; Deng X; Liu W
Cell Rep; 2023 Nov; 42(11):113385. PubMed ID: 37938975
[TBL] [Abstract][Full Text] [Related]
14. The splicing factor SRSF1 stabilizes the mRNA of TSLP to enhance acute lung injury.
Fu C; Hu Y; Liu J; Yang Y
Cell Immunol; 2021 Apr; 362():104299. PubMed ID: 33607522
[TBL] [Abstract][Full Text] [Related]
15. Serine and arginine rich splicing factor 1 deficiency alters pathways involved in IL-17A expression and is implicated in human psoriasis.
Su S; Katopodi XL; Pita-Juarez YH; Maverakis E; Vlachos IS; Adamopoulos IE
Clin Immunol; 2022 Jul; 240():109041. PubMed ID: 35613697
[TBL] [Abstract][Full Text] [Related]
16. SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance.
Sheng J; Zhao Q; Zhao J; Zhang W; Sun Y; Qin P; Lv Y; Bai L; Yang Q; Chen L; Qi Y; Zhang G; Zhang L; Gu C; Deng X; Liu H; Meng S; Gu H; Liu Q; Coulson JM; Li X; Sun B; Wang Y
EBioMedicine; 2018 Dec; 38():113-126. PubMed ID: 30429088
[TBL] [Abstract][Full Text] [Related]
17. AMP-activated protein kinase regulates alternative pre-mRNA splicing by phosphorylation of SRSF1.
Matsumoto E; Akiyama K; Saito T; Matsumoto Y; Kobayashi KI; Inoue J; Yamamoto Y; Suzuki T
Biochem J; 2020 Jun; 477(12):2237-2248. PubMed ID: 32453427
[TBL] [Abstract][Full Text] [Related]
18. Regnase-1 downregulation promotes pancreatic cancer through myeloid-derived suppressor cell-mediated evasion of anticancer immunity.
Okabe J; Kodama T; Sato Y; Shigeno S; Matsumae T; Daiku K; Sato K; Yoshioka T; Shigekawa M; Higashiguchi M; Kobayashi S; Hikita H; Tatsumi T; Okamoto T; Satoh T; Eguchi H; Akira S; Takehara T
J Exp Clin Cancer Res; 2023 Oct; 42(1):262. PubMed ID: 37814340
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet.
Luo Y; Yang Y; Liu M; Wang D; Wang F; Bi Y; Ji J; Li S; Liu Y; Chen R; Huang H; Wang X; Swidnicka-Siergiejko AK; Janowitz T; Beyaz S; Wang G; Xu S; Bialkowska AB; Luo CK; Pin CL; Liang G; Lu X; Wu M; Shroyer KR; Wolff RA; Plunkett W; Ji B; Li Z; Li E; Li X; Yang VW; Logsdon CD; Abbruzzese JL; Lu W
Gastroenterology; 2019 Nov; 157(5):1413-1428.e11. PubMed ID: 31352001
[TBL] [Abstract][Full Text] [Related]
20. RNA splicing is a key mediator of tumour cell plasticity and a therapeutic vulnerability in colorectal cancer.
Hall AE; Pohl SÖ; Cammareri P; Aitken S; Younger NT; Raponi M; Billard CV; Carrancio AB; Bastem A; Freile P; Haward F; Adams IR; Caceres JF; Preyzner P; von Kriegsheim A; Dunlop MG; Din FV; Myant KB
Nat Commun; 2022 May; 13(1):2791. PubMed ID: 35589755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
